Pernix Adds Generics And Branded Drugs With $101 Million Buy
This article was originally published in The Pink Sheet Daily
Executive Summary
Texas-based Pernix Therapeutics will acquire Cypress Pharmaceuticals and Hawthorn Pharmaceuticals, privately owned generic and branded pharmaceutical companies, respectively.